Caroline Baumal - Chief Medical Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

Caroline Baumal - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Caroline Baumal for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 86,527 $1,883,294 $21.77 22 Jan 2026 Direct
Stock Option (Right to Buy) 82,500 $1,599,675 $19.39 09 Jun 2025 Direct Common Stock

Transactions reported by Caroline Baumal for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.